Face App Helps to Spot Rare Diseases

April 17, 2017

The Times of London 

“Doctors are using a smartphone app that can scan photos for the facial characteristics of more than 2,000 genetic syndromes within seconds. The Face2Gene app is being introduced at St Mary’s Hospital, Manchester, to help in the diagnosis of children with rare conditions. It was developed by a Boston-based team that includes the creators of the facial recognition software bought by Facebook.”

 

The article from The Times discusses how Face2Gene, a facial recognition app, is aiding in the expedite of diagnosis of rare disorders and diseases. Utilizing artificial intelligence, Face2Gene analyzes facial features from photographs to identify signs of various genetic disorders and syndromes. This innovative decision support tool assists healthcare professionals by providing quick and accurate preliminary diagnoses, particularly valuable in areas lacking genetic specialists. It highlights the app’s role in transforming genetic disorder diagnostics with over 200 conditions currently recognizable through its database. The platform’s vast database and collaborative network equip geneticists with extensive knowledge, enabling more accurate diagnoses in less time.

Read More

Share this article

Most popular news

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading